quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:01:19·57d
SECFiling
Immunocore Holdings plc logo

SEC Form 10-K filed by Immunocore Holdings plc

IMCR· Immunocore Holdings plc
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • IMCR
    Immunocore Holdings plc
    Health Care

Recent analyst ratings

  • Mar 16UpdateJefferies$33.00
  • Jan 7UpdateUBS$55.00
  • Oct 31UpdateWells Fargo$60.00
  • Sep 18UpdateGuggenheim-
  • Aug 25UpdateJefferies$48.00
  • May 27UpdateDeutsche Bank$65.00

Related

  • PR4d
    KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
  • SEC7d
    SEC Form DEF 14A filed by Immunocore Holdings plc
  • PR17d
    Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
  • PR37d
    Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
  • ANALYST38d
    Immunocore downgraded by Jefferies with a new price target
  • SEC48d
    Amendment: SEC Form SCHEDULE 13G/A filed by Immunocore Holdings plc
  • PR49d
    Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
  • PR51d
    Immunocore to present at upcoming investor conferences
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022